Skip to content

Author

Pardeep Kumar

We have 3 of 23 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Computational small molecule drug discovery for multidrug-resistant tuberculosis: emerging targets and recent medicinal chemistry advances.

Tuberculosis (TB) remains a major global health challenge, further intensified by the emergence of multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains, which compromise the effectiveness of existing therapeutic regimens. Despite significant progress in TB chemotherapy, prolonged treatment durat...

Pardeep Kumar, Ankita Devi, Sridevi Bhima et al. · 2 citations
Open access Sep 2026

Exploration of novel indolo[2,3-b]quinoxaline hybrids as InhA inhibitors: A multi-disciplinary approach involving synthesis, antimycobacterial evaluation and computational studies.

A library of 52 indolo[2,3-b]quinoxaline derivatives was designed and synthesized using a pharmacophore-hybridization strategy and subjected to comprehensive biological and computational evaluation, highlighting indolo[2,3-b]quinoxaline as promising antitubercular scaffold for further development.

Sri Mounika Bellapukonda, Akanksha, Mainak Ghosh et al. · 1 citation
Open access Sep 2026

Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole‐Based Hydrazide Derivatives as Potential Anti‐Tuberculosis Agents

Findings highlight the potential of benzisothiazole‐based hydrazide derivatives as promising scaffolds for the development of new antitubercular agents and suggest InhA as a potential molecular target.

V. Sharma, Arun Sharma, Ruchi Poria et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.